Segment Information and Concentrations of Risk (Tables)

12 Months Ended

Dec. 31, 2012

Segment Information and Concentrations of Risk Disclosure [Abstract]

Segment Financial Information

The following tables present operating group financial information for the periods indicated.

	Year ended December 31, 2012
	Healthcare		DNA			Total
Net sales:
Software and other	$	78,941	$	15,525		$	94,466
Professional Services		27,552		13,426			40,978
Maintenance and EDI		110,894		2,566			113,460
Total net sales	$	217,387	$	31,517		$	248,904
Expenses		192,408		33,315			225,723
Segment income (loss)	$	24,979	$	(1,798	)		23,181
Net corporate/other expenses (1)							47,910
Loss before income taxes						$	(24,729	)

	Year ended December 31, 2011
	Healthcare		DNA		Total
Net sales:
Software and other	$	76,947	$	4,001	$	80,948
Professional Services		23,437		18,468		41,905
Maintenance and EDI		109,562		13		109,575
Total net sales	$	209,946	$	22,482	$	232,428
Expenses		166,898		20,406		187,304
Segment income (loss)	$	43,048	$	2,076		45,124
Net corporate/other expenses (1)						46,990
Loss before income taxes					$	(1,866	)

	Year ended December 31, 2010
	Healthcare		DNA			Total
Net sales:
Software and other	$	42,379	$	41		$	42,420
Professional Services		13,183		9,992			23,175
Maintenance and EDI		74,737		-			74,737
Total net sales	$	130,299	$	10,033		$	140,332
Expenses		118,179		10,808			128,987
Segment income (loss)	$	12,120	$	(775	)		11,345
Net corporate/other expenses (1)							36,507
Loss before income taxes						$	(25,162	)

(1) Net corporate/other expenses include public company costs, corporate administration expenses, amortization expense which is not attributable to business segments, acquisition-related expenses and net interest expense.

	Healthcare		DNA		Corporate/ Other			Consolidated
Depreciation and amortization
Year ended December 31, 2012	$	16,049	$	4,187	$	59		$	20,295
Restructuring and Other One Time Charges
Year ended December 31, 2012	$	333	$	497	$	-		$	830
Assets as of December 31, 2012	$	412,841	$	33,207	$	(9,195	)	$	436,853

	Healthcare		DNA		Corporate/ Other		Consolidated
Depreciation and amortization
Year ended December 31, 2011	$	19,311	$	2,165	$	732	$	22,208
Restructuring and Other One Time Charges
Year ended December 31, 2011	$	1,216	$	-	$	-	$	1,216
Assets as of December 31, 2011	$	354,442	$	47,722	$	48,223	$	450,387

	Healthcare		DNA		Corporate/ Other		Consolidated
Depreciation and amortization
Year ended December 31, 2010	$	15,702	$	1,820	$	290	$	17,812
Restructuring and Other One Time Charges
Year ended December 31, 2010	$	4,578	$	10	$	418	$	5,006
Assets as of December 31, 2010	$	326,037	$	29,764	$	40,844	$	396,645

Segment Financial Information by Customer Location

The following tables present certain geographic information, based on location of customer:

	Net Sales
	Years Ended December 31,
	2012		2011		2010
United States of America	$	232,848	$	211,907	$	125,974
Europe		8,687		8,767		7,730
Japan		2,190		5,312		2,853
Korea		1,018		1,449		718
Canada		1,707		1,598		491
Other		2,454		3,395		2,566
Total Net Sales	$	248,904	$	232,428	$	140,332

	Long Lived Assets
	December 31, 2012		December 31, 2011		December 31, 2010
United States of America		4,316		3,866		5,105
Canada		569		520		606
Europe		79		3		56
Other		-		2		5
Total	$	4,964	$	4,391	$	5,772